Panbela Therapeutics, Inc. Interest Payable, Current
Panbela Therapeutics, Inc. had Interest Payable, Current of $523.00 thousand as of 2024-09-30, per its 10-Q filed 2024-11-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:InterestPayableCurrent · last filed 2024-11-14
- 2024-09-30: Interest Payable, Current $523.00K.
- 2024-06-30: Interest Payable, Current $87.00K.
- 2024-03-31: Interest Payable, Current $34.00K.
- 2023-12-31: Interest Payable, Current $238.00K.
| Period end | Interest Payable, Current |
|---|---|
| 2024-09-30 | $523.00K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $87.00K 10-Q · filed 2024-08-13 |
| 2024-03-31 | $34.00K 10-Q · filed 2024-05-15 |
| 2023-12-31 | $238.00K 10-Q · filed 2024-11-14 |
| 2023-09-30 | $172.00K 10-Q · filed 2023-11-09 |
| 2023-06-30 | $107.00K 10-Q · filed 2023-08-10 |
| 2023-03-31 | $42.00K 10-Q · filed 2023-05-04 |
| 2022-12-31 | $325.00K 10-K · filed 2024-03-26 |
| 2022-09-30 | $150.00K 10-Q · filed 2022-11-10 |
| 2022-06-30 | $66.00K 10-Q · filed 2022-08-15 |
| 2021-12-31 | $0.00 10-K · filed 2023-03-16 |
| 2019-09-30 | $1.00K 10-Q · filed 2019-11-13 |
| 2019-06-30 | $1.00K 10-Q · filed 2019-08-13 |
| 2019-03-31 | $52.00K 10-Q · filed 2019-05-14 |
| 2018-12-31 | $4.00K 10-Q · filed 2019-11-13 |
| 2018-09-30 | $5.00K 10-Q · filed 2018-11-05 |
| 2018-06-30 | $41.00K 10-Q · filed 2018-08-13 |
| 2018-03-31 | $224.00K 10-Q · filed 2018-05-14 |
| 2017-12-31 | $181.00K 10-K · filed 2019-03-22 |
| 2017-09-30 | $57.00K 10-Q · filed 2017-11-14 |
| 2017-06-30 | $58.00K 10-Q · filed 2017-08-10 |
| 2017-03-31 | $55.00K 10-Q · filed 2017-05-11 |
| 2016-12-31 | $155.00K 10-K · filed 2018-03-21 |
| 2016-09-30 | $70.00K 10-Q · filed 2016-11-10 |
| 2016-06-30 | $35.00K 10-Q · filed 2016-08-11 |
| 2016-03-31 | $35.00K 10-Q · filed 2016-05-12 |
| 2015-12-31 | $35.00K 10-K · filed 2017-03-30 |
| 2014-12-31 | $38.00K 10-K · filed 2016-03-08 |